Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Kahn SB"'
Autor:
King Rs, Isadore Brodsky, Meglathery Sb, Ener Ra, David Topolsky, Kahn Sb, Pamela Crilley, Michael Styler, Cuhaci B
Publikováno v:
American Journal of Clinical Oncology: Cancer Clinical Trials. 24:19-25
Administration of granulocyte colony-stimulating factor to patients undergoing high-dose chemotherapy and autologous peripheral blood stem cell transplantation accelerates neutrophil recovery and decreases hospitalization time. The optimal timing for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b51fc966d08209dd5452412448ff3782
https://doi.org/10.1097/00000421-200102000-00003
https://doi.org/10.1097/00000421-200102000-00003
Autor:
Pamela Crilley, Isadore Brodsky, J Weiss, James F. Conroy, David Topolsky, S Bulova, J Gryn, Kahn Sb
Publikováno v:
American Journal of Clinical Oncology. 14:52-54
Thirteen patients with leukemia were treated with a combination of cytosine arabinoside (ara-C) (3 g/m2 by 1-h infusion every 12 h for 12 doses) and etoposide (100 mg/m2 daily over 1 h for 3 doses). Toxicity of the regimen consisted of severe hematol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1c9a2997b4b3d97172692adeafdb12
https://doi.org/10.1097/00000421-199102000-00012
https://doi.org/10.1097/00000421-199102000-00012
Autor:
Kelch Bp, David Topolsky, Isadore Brodsky, S Bulova, Peter S. Amenta, James F. Conroy, Kahn Sb, Pamela Crilley
Publikováno v:
American journal of clinical oncology. 13(3)
Recurrent leukemia following allogeneic bone marrow transplantation (BMT) for acute nonlymphocytic leukemia (ANLL) continues to be a cause of morbidity and mortality. Most relapses occur within the first 6-12 months, although disease-free survival cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0b7af208174cf423abe7023819a0621
https://pubmed.ncbi.nlm.nih.gov/2346129
https://pubmed.ncbi.nlm.nih.gov/2346129
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
American Journal of Clinical Oncology. 12:201-204
Seventeen elderly patients with acute nonlymphocytic leukemia (EP-ANLL) were treated with cytarabine, either 1.5 g/m2 or 2.0 g/m2 q 12 h for 4 days [attenuated high-dose ARA-C (HDARAC)]. One complete and one partial response was seen in 15 evaluable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6d6c2655f066a87980a48eb67ad4a3
https://doi.org/10.1097/00000421-198906000-00004
https://doi.org/10.1097/00000421-198906000-00004
Publikováno v:
Journal of Cardiothoracic Anesthesia. 2:837-840
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9762c834e9369f79bde954c8298c69d0
https://doi.org/10.1016/0888-6296(88)90110-x
https://doi.org/10.1016/0888-6296(88)90110-x
Publikováno v:
American Journal of Clinical Oncology. 10:78-81
Twenty-two evaluable adult patients with relapsed, acute nonlymphocytic leukemia (ANLL) were treated with the combination of amsacrine (m-AMSA.) and 5-azacytidine (AZA) as part of an Eastern Cooperative Oncology Group (ECOG) pilot study to evaluate e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e5caf08e2f4a2a334480e626150bbe7
https://doi.org/10.1097/00000421-198702000-00017
https://doi.org/10.1097/00000421-198702000-00017
Publikováno v:
Blood; April 1984, Vol. 63 Issue: 4 p843-847, 5p
Publikováno v:
American journal of clinical pathology. 50(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066c068b3d22b0ab4ce9cd5e88c1d89a
https://pubmed.ncbi.nlm.nih.gov/5673086
https://pubmed.ncbi.nlm.nih.gov/5673086